3D心臓マッピングの中国市場2020–2027:用途別(電気解剖学的マッピング、バスケットカテーテルマッピング、リアルタイム位置管理EPシステム)、エンドユーザー別

【英語タイトル】China 3D cardiac mapping Market by Application (Electroanatomical Mapping, Basket Catheter Mapping, and Real-Time Positional Management EP System) and End User (Hospitals, Clinics, and Diagnostics Centers): Opportunity Analysis and Industry Forecast, 2020-2027

Allied Market Researchが出版した調査資料(AMR20PL074)・商品コード:AMR20PL074
・発行会社(調査会社):Allied Market Research
・発行日:2020年6月
・ページ数:75
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:中国
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,979 ⇒換算¥321,732見積依頼/購入/質問フォーム
5 UserUSD3,099 ⇒換算¥334,692見積依頼/購入/質問フォーム
Enterprise UserUSD4,322 ⇒換算¥466,776見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

The China 3D cardiac mapping market was valued at $55.55 million in 2019 and is projected to reach $150.59 million by 2027, registering a CAGR of 12.8% from 2020 to 2027.

Cardiac mapping is the process of identifying electrical or mechanical activity of human heart. Mapping electrical movements of heart is a critical component for diagnosis and treatment of any heart disease. Cardiac mapping is generally performed by inserting a catheter into the heart chamber percutaneously and sequentially recording endocardial electrograms within a precise location within the heart. 3D cardiac mapping systems give three-dimensional view of a patient’s heart, which helps electrophysiologists to identify the site of origin of any irregular rhythm accurately and deliver radio-frequency catheter ablation therapy with high success rate. Moreover, cardiac mapping is used widely for identification, characterization, and localization of arrhythmia.

Surge in prevalence of cardiac arrhythmias and increased demand for improved patient outcomes mainly boosts the market growth. Cardiac arrhythmias have increased the incidences of other risk factors such as CVDs, high blood pressure, obesity, and diabetes. The chances of developing cardiac arrhythmias increases with increase in age. The common type of cardiac arrhythmias is atrial fibrillation, which causes an irregular and fast heart beat; there are numerous factors responsible for irregular heart rhythm such as heart attack, smoking, congenital heart defects, and stress. Improving life expectancies of people has considerably increased the geriatric population across the globe. These aspects have increased the demand for early detection and treatment of irregular heartbeat, thereby driving the demand for 3D cardiac mapping systems.

The China 3D cardiac mapping market is segmented on the basis of application and end user. By application, it is divided into electroanatomical mapping, basket catheter mapping, and real-time positional management (cardiac pathways) EP system. By end user, it is segmented into hospitals, clinics and diagnostics centers
Some of the key players operating in the market include Abbott Laboratories, Microport Scientific Corporation, Medtronic Plc, and Acutus Medical.

KEY MARKET SEGMENTS
By Application
• Electroanatomical Mapping
• Basket Catheter Mapping
• Real-Time Positional Management (Cardiac Pathways) EP System.

By End User
• Hospitals
• Clinics
• Diagnostics

LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Abbott Laboratories
• Microport Scientific Corporation
• Medtronic Plc
• Acutus Medical

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Surge in prevalence of cardiac arrhythmias
3.4.1.2.Rise in geriatric population.
3.4.1.3.Growth in preference for minimally invasive procedures

3.4.2.Restraint

3.4.2.1.High Cost of 3D Cardiac Mapping Systems

3.4.3.Opportunity

3.4.3.1.Rise in Preference for 3D Cardiac Mapping
3.4.3.2.Rise in the Healthcare Expenditure in China

3.5.Impact of government regulations on China 3d cardiac mapping market

CHAPTER 4:CHINA 3D CARDIAC MAPPING MARKET, BY TECHNOLOGY

4.1.Overview

4.1.1.Market size and forecast

4.2.Electroanatomical mapping

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region

4.3.Basket catheter mapping

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region

4.4.Real-time positional management (cardiac pathways) EP system

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region

CHAPTER 5:CHINA 3D CARDIAC MAPPING MARKET, BY END USER

5.1.Overview

5.1.1.Market size and forecast

5.2.Hospitals

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast

5.3.Clinics

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast

5.4.Diagnostics centers

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast

CHAPTER 6:COMPANY PROFILES

6.1.Abbott Laboratories

6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance
6.1.6.Key strategic moves and developments

6.2.Acutus Medical

6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
6.2.5.Key strategic moves and developments

6.3.MicroPort Scientific Corporation

6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio
6.3.5.Business performance.

6.4.Medtronic Plc.

6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Product portfolio
6.4.5.Business performance
6.4.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.CHINA 3D CARDIAC MAPPING MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 02.CHINA 3D CARDIAC MAPPING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 03.ABBOTT: COMPANY SNAPSHOT
TABLE 04.ABBOTT: OERATING SEGMENT
TABLE 05.ABBOTT: PRODUCT PORTFOLIO
TABLE 06.ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 07.ACUTUS: COMPANY SNAPSHOT
TABLE 08.ACUTUS: OPERATING SEGMENTS
TABLE 09.ACUTUS: PRODUCT PORTFOLIO
TABLE 10.ACUTUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 11.MICROPORT: COMPANY SNAPSHOT
TABLE 12.MICROPORT: OPERATING SEGMENTS
TABLE 13.MICROPORT: PRODUCT PORTFOLIO
TABLE 14.MEDTRONIC: COMPANY SNAPSHOT
TABLE 15.MEDTRONIC: OPERATING BUSINESS SEGMENTS
TABLE 16.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 17.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS

★調査レポート[3D心臓マッピングの中国市場2020–2027:用途別(電気解剖学的マッピング、バスケットカテーテルマッピング、リアルタイム位置管理EPシステム)、エンドユーザー別] (コード:AMR20PL074)販売に関する免責事項を必ずご確認ください。
★調査レポート[3D心臓マッピングの中国市場2020–2027:用途別(電気解剖学的マッピング、バスケットカテーテルマッピング、リアルタイム位置管理EPシステム)、エンドユーザー別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆